Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases

Ho, Faith C. S.; Choy, D.; Loke, S. L.; Kung, I. T. M.; Fu, K. H.; Liang, Raymond; Todd, D.; Khoo, R. K. K.

doi:10.1016/0046-8177(90)90254-3

Cited by 156 publications

(71 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[5][6][7] Furthermore, clonal Epstein-Barr viral infection has been documented in many of these cases. 6 Patients with primary nasal lymphoma usually present Primary nasal T or NK cell lymphoma is rarely seen in the Western population but is more common in the with local nasal symptoms and the tumour is often clinically localised.…”

mentioning

confidence: 99%

Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma

Liang

Chen

Lee

et al. 1997

Bone Marrow Transplant

View full text Add to dashboard Cite

Summary:ently negative. [5][6][7] Furthermore, clonal Epstein-Barr viral infection has been documented in many of these cases. 6 Patients with primary nasal lymphoma usually present Primary nasal T or NK cell lymphoma is rarely seen in the Western population but is more common in the with local nasal symptoms and the tumour is often clinically localised. 3,8 However, the prognosis is generally poor Orientals. Although it often presents with localized disease, the prognosis is generally poor. Long-term as compared with their nodal counterparts. 8 Durable remission is only seen in around 50% of stage I patients remission is seen in only 50% of patients with stage I disease despite aggressive treatment with chemotherapy and the disease is invariably fatal if disseminated. For patients with relapsed disease, the prognosis is also dismal and radiotherapy, and is invariably fatal if disseminated. Conventional chemotherapy for relapsed disease as they almost all die with progressive disease within 1 year from the time of relapse. High-dose chemotherapy and is usually not successful. Since 1992, three patients with relapsed primary nasal T/NK cell lymphoma have autologous stem cell rescue has been shown to be an effective therapy for patients with relapsed aggressive nonreceived high-dose chemotherapy with autologous bone marrow rescue at Queen Mary Hospital, Hong Kong.Hodgkin's lymphoma. 9 We report our experience of using the approach to manage three patients with relapsed priHigh-dose cyclophosphamide, BCNU and etoposide were used for conditioning. Two of them had a favourmary nasal lymphoma. able response and remained in complete remission at 12 and 44 months post-transplant. The third patient unfortunately had a systemic relapse 6 months after the Case report transplant. It appears from this experience that, like other aggressive non-Hodgkin's lymphomas, high-dose Since 1992, three Chinese patients with relapsed primary nasal T/NK cell lymphoma have received high-dose chemochemotherapy and autologous bone marrow rescue is an effective treatment for relapsed primary nasal lymtherapy and autologous bone marrow rescue at the Bone Marrow Transplantation Unit of Queen Mary Hospital, phoma following failure of conventional chemotherapy and radiotherapy.Hong Kong. Their clinical characteristics are shown in Table 1. The conditioning regimen consisted of cyclophosKeywords: nasal lymphoma; autologous bone marrow transplantation phamide 1.8 g/m 2 /day for 4 days, BCNU 100 mg/m 2 /day for 3 days and etoposide 400 mg/m 2 12 h for six doses. The first patient was a 30-year-old woman. She presented with a nasal mass and symptoms of nasal obstruction in Primary nasal lymphoma is extremely uncommon in the February 1992. Biopsy of the tumour revealed a primary Western population. When it occurs, it often affects the nasal lymphoma (CD2 + , CD56 + ). Staging investigations nasal sinuses and is usually of B cell origin. On the other confirmed that she had disease localised to the nasal cavity. hand, it is much more common in the Orie...

show abstract

mentioning

confidence: 99%

Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma

Liang

Chen

Lee

et al. 1997

Bone Marrow Transplant

View full text Add to dashboard Cite

show abstract

“…However, the usual absence of other T-lineage antigens, such as CD4, CD5, CD8, and surface CD3 (Chan et al, 1987;Jaffe et al, 1996), the frequent presence of germ-line T-cell receptor (TcR) genes (Ho et al, 1990a;Jaffe et al, 1996), and, in most cases, the expression of a natural killer (NK)-cell marker, CD56 (Ho et al, 1990a;Jaffe, 1995Jaffe, , 1996Kanavaros et al, 1993;Suzumiya et al, 1994), raise doubts about the true nature of this lymphoma. The term "nasal T/NK-cell lymphoma" was proposed in 1994 to reflect the existence of the characteristics of both T cells and NK cells .…”

mentioning

confidence: 99%

“…Furthermore, CD56 is usually but not always positive in NK/T-cell lymphomas. A combined genotype of germ-line TcR is mandatory for the diagnosis of NK/ T-cell lymphoma, but rare cases with clonal gene rearrangement have also been reported (Gaulard et al, 1988;Ho et al, 1990a;1990b;Kanavaros et al, 1993). Despite the lack of specific markers, a combination of morphology; phenotypic features such as the presence of CD56 and CD3⑀ and lack of CD5; and genotype of the germ-line TcR gene is currently acceptable for diagnosis of NK/T-cell lymphoma .…”

mentioning

confidence: 99%

“…The involved tissues display features of pleomorphic tumor cells that are variably associated with angiocentric and angiodestructive growth as well as zonal coagulative necrosis. Thus, the lesions have been designated by terms such as midline lethal granuloma, polymorphic reticulosis, or angiocentric lymphoma, reflecting the unique features of the tumors (Ho et al, 1990aJaffe et al, 1996.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Expression of Cyclin-Dependent Kinase 6 (cdk6) and Frequent Loss of CD44 in Nasal-Nasopharyngeal NK/T-Cell Lymphomas: Comparison with CD56-Negative Peripheral T-Cell Lymphomas

Lien

Lin

Huang

et al. 2000

Laboratory Investigation

View full text Add to dashboard Cite

“…3 Horny et al analyzed the published data and stated that most of these lesions are initially seen as nonulcerated smooth or polypoid masses in the epiglottis and the arytenoepiglottic folds. 8,22 Subsite classification include 47% in supraglottis, 25% in glottis and rest present as subglottic or transglottic. 3 Supraglottic region has rich lymphoid aggregations in the lamina propria so the higher incidence.…”

Section: Discussionmentioning

confidence: 99%